PubMedApril 17, 2026
Coronary Artery Calcium Progression in Heart Transplant Recipients
by Sharma Simran P
Coronary artery calcium progression is common in heart transplant recipients, with significant implications for cardiovascular health and management strategies.
Key Findings
- 1Over half (65 out of 116) of heart transplant recipients showed progression in coronary artery calcium scores during follow-up.
- 2The annual increase in CAC scores was found to be 55%, indicating a significant rise in atherosclerotic burden.
- 3Younger donor heart age was independently associated with faster CAC progression, emphasizing the importance of donor characteristics.
- 4Factors such as recipient age, sex, and ischemic cardiomyopathy also influenced the rate of CAC progression.
Coronary artery calcium (CAC) scoring is a critical tool in assessing atherosclerotic burden, particularly in populations at risk, such as heart transplant (HT) recipients. This study sheds light on the progression of CAC in these patients over a long-term follow-up period, revealing important insights into cardiovascular health post-transplantation. Understanding CAC progression is vital as it can indicate the risk of cardiovascular events, which are a leading cause of morbidity and mortality in this population.
In a cohort of 116 adult heart transplant recipients, researchers found that 65 patients exhibited CAC progression over time. The study reported a notable annual increase in CAC scores, with a relative yearly increase of 55%. Factors influencing this progression included recipient age, donor heart age, sex, and the presence of ischemic cardiomyopathy. Specifically, younger donor heart age was independently linked to faster CAC progression, highlighting the importance of donor characteristics in post-transplant cardiovascular health.
For individuals who have undergone heart transplantation, these findings underscore the necessity for regular monitoring of CAC scores. By identifying patients at higher risk for cardiovascular events, healthcare providers can implement more aggressive management strategies, potentially improving long-term outcomes. This may include lifestyle interventions, medication adjustments, and closer surveillance of cardiovascular health.
The findings also connect to several biomarkers relevant to metabolic health. Monitoring fasting insulin and glucose levels can provide insights into insulin resistance, which is a risk factor for cardiovascular disease. Additionally, tracking inflammation markers such as hsCRP may help assess the overall cardiovascular risk in these patients. Regular evaluations of lipid profiles, including triglycerides and HDL levels, are also crucial as they relate to the overall metabolic status and cardiovascular health.
In conclusion, the progression of coronary artery calcium in heart transplant recipients is a significant concern that warrants attention. With donor heart age being a key factor, it is essential for both patients and healthcare providers to prioritize cardiovascular health monitoring and management strategies to mitigate risks and enhance long-term health outcomes.
Related Biomarkers
HOMA IRHSCRPTRIGLYCERIDESHDL
Calculate & Evaluate on Metabolicum
Original Source
DOI (Digital Object Identifier) is a permanent link to this publication. Unlike website URLs that can change, a DOI always resolves to the correct source.